Leadership & Pay ·
BioAtla reinstates retention and performance bonus programs for CEO Dr. Jay Short and CFO Christian Vasquez due to missed earlier milestones
BCABBioAtla, Inc.
BioAtla, Inc. reported that Dr. Eric Sievers resigned as Chief Medical Officer on September 25, 2026, to pursue outside interests while continuing as a consultant through June 30, 2027. His consulting agreement includes a one-time payment of $159,000 contingent on capital raising milestones by December 31, 2026, plus hourly compensation thereafter. The Board also reinstated retention and performance bonus programs for CEO Dr. Jay Short and CFO Christian Vasquez due to missed earlier milestones. Dr. Short’s target retention bonus is $440,892 and performance bonus is $220,000; Mr. Vasquez’s targets are $148,888 and $75,000 respectively. These payouts depend on financial and capital raising milestones achieved by December 31, 2026, or March 31, 2027. BioAtla operates in the biotechnology industry, focusing on developing antibody-drug conjugates for cancer treatment.